Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Valued at a market cap of $9.6 billion, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that ...

Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for ...

Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad ...

Cartesian Therapeutics, Inc.’s RNAC share price has dipped by 5.62%, which has investors questioning if this is right time to ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

For years, Robert F. Kennedy Jr. has raised questions about vaccine safety. Now, as the Secretary of Health and Human ...

Arcturus Therapeutics Holdings Inc.’s ARCT share price has surged by 6.84%, which has investors questioning if this is right ...

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives. That same mRNA-powered approach to medicine—in which synthetic mRNA is ...